“`html
GLJ Research initiated coverage of Argan (NYSE:AGX) on September 22, 2025, with a Hold recommendation. The average one-year price target for the stock is $252.45/share, indicating a 5.92% downside from its latest closing price of $268.33/share.
Projected annual revenue for Argan is $832 million, down 9.60%, while the projected non-GAAP EPS is $6.60, reflecting a 43.54% increase from the previous forecast. There are 661 funds reporting positions in Argan, an increase of 14.36% over the last quarter, with total institutional shares rising by 6.43% to 14,459,000 shares.
“`
